• Activity INFORMATION

  Overview

  This session is part of the General Pain Specialty Series, which explores overall pain management considerations, best practices, and pain conditions. This module discusses the two varying styles of urine drug monitoring including both urine drug screening (UDS) and urine drug testing (UDT). This module will also discuss anticipated UDS/UDT results based on prescribed medications and utilized substances, along with common cross-reactants for controlled substances in urine drug screenings (UDS).
  

  Handouts

  • Slide Document :   22160H08_2pp.pdf Download

  • Slide Document :   22160H08_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recall common cross-reactants for controlled substances in urine drug screenings (UDS)

  Identify the clinical practice implication differences between urine drug screenings (UDS) and urine drug tests (UDT)

  Describe anticipated results of urine drug screenings (UDS) and urine drug tests (UDT), based on prescribed medications and utilized substances

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-919081

  Universal Activity Number

  Pharmacist 0798-0000-22-160-H08-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).